Blood Pressure Pills Recalled Nationwide Over Metal

Breckenridge Pharmaceutical recalled one lot of 60mg Propranolol extended-release capsules nationwide over possible metal contamination.

@sharedot

Blood Pressure Pills Recalled Nationwide Over Metal

By @sharedot · · 6 pages

  • Health
  • Drug Recall
  • FDA
  • Blood Pressure

Breckenridge Pharmaceutical recalled one lot of 60mg Propranolol extended-release capsules nationwide over possible metal contamination.

A nationwide recall of a common beta-blocker

Breckenridge Pharmaceutical, Inc. issued a voluntary consumer-level recall on Monday for one lot of Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg, which are used mainly to treat high blood pressure but also for chest pain, migraines or tremors.

According to Fox Business, the recalled capsules may contain metal fragments that could cause lacerations. The affected product comes in 100-count bottles with lot number PK25110035, National Drug Code 51991-817-01 and an expiration date of May 2029.

Why the contamination is alarming

The stakes go beyond a labeling error: a company statement quoted by Fox Business warns that use of product from the affected lot 'could potentially cause lacerations of soft tissues in the oral cavity, esophagus, stomach, or intestine,' meaning swallowing a contaminated capsule could tear tissue along the entire digestive tract.

The company traced the problem to intermediate material shared with a separate lot that was never released to market, where the suspected metal contamination was identified.

Both outlets report Breckenridge is not aware of any adverse events connected to the recall so far, which suggests the risk is precautionary but explains why regulators and the company moved quickly to pull the pills from shelves nationwide.

What patients should do now

The recall notice tells consumers to immediately stop taking product from the affected lot and contact their physician or healthcare provider for medical advice and replacement instructions, rather than abruptly managing blood pressure on their own.

Patients should return any unused portion of the product to the pharmacy where it was obtained, and anyone who experiences a problem possibly related to the pills is urged to report it through the FDA's MedWatch Adverse Event Reporting program.

Wholesalers, pharmacies and other retailers are directed to check inventory, quarantine any affected product and refrain from dispensing it. NBC 5 Chicago notes Breckenridge Pharmaceutical did not immediately respond to its request for comment.

A pattern of blood pressure drug recalls

This recall lands in a wave of recent quality problems affecting blood pressure medications.

According to NBC 5 Chicago, earlier this month Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide tablets were recalled because they did not dissolve properly, and earlier this fall thousands of bottles of Chlorthalidone tablets were recalled for the same reason.

It also follows a pattern that health-savvy consumers should watch: checking lot numbers and NDCs on any prescription in the cabinet against active FDA recall notices is now a routine safety step.

Sources

  1. foxbusiness.com › Blood pressure drug recalled nationwide over possible metal contamination
  2. nbcchicago.com › Nationwide recall issued for blood pressure medication over possible metal contamination

More on Health